Gatliff J - Search Results

1

A role for TSPO in mitochondrial Ca²⁺ homeostasis and redox stress signaling.

Gatliff J, East DA, Singh A, Alvarez MS, Frison M, Matic I, Ferraina C, Sampson N, Turkheimer F, Campanella M. Gatliff J, et al. Cell Death Dis. 2017 Jun 22;8(6):e2896. doi: 10.1038/cddis.2017.186. Cell Death Dis. 2017. PMID: 28640253 Free PMC article.

2

TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control.

Gatliff J, East D, Crosby J, Abeti R, Harvey R, Craigen W, Parker P, Campanella M. Gatliff J, et al. Autophagy. 2014;10(12):2279-96. doi: 10.4161/15548627.2014.991665. Autophagy. 2014. PMID: 25470454 Free PMC article.

3

TSPO is a REDOX regulator of cell mitophagy.

Gatliff J, Campanella M. Gatliff J, et al. Biochem Soc Trans. 2015 Aug;43(4):543-52. doi: 10.1042/BST20150037. Epub 2015 Aug 3. Biochem Soc Trans. 2015. PMID: 26551691 Review.

4

TSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria.

Gatliff J, Campanella M. Gatliff J, et al. Biochem J. 2016 Jan 15;473(2):107-21. doi: 10.1042/BJ20150899. Biochem J. 2016. PMID: 26733718 Review.

5

The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology.

Gatliff J, Campanella M. Gatliff J, et al. Curr Mol Med. 2012 May;12(4):356-68. doi: 10.2174/1566524011207040356. Curr Mol Med. 2012. PMID: 22364127 Review.

6

The compound BTB06584 is an IF1 -dependent selective inhibitor of the mitochondrial F1 Fo-ATPase.

Ivanes F, Faccenda D, Gatliff J, Ahmed AA, Cocco S, Cheng CH, Allan E, Russell C, Duchen MR, Campanella M. Ivanes F, et al. Among authors: gatliff j. Br J Pharmacol. 2014 Sep;171(18):4193-206. doi: 10.1111/bph.12638. Epub 2014 Jul 1. Br J Pharmacol. 2014. PMID: 24641180 Free PMC article.

7

Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids.

Georgakopoulos ND, Talapatra SK, Gatliff J, Kozielski F, Wells G. Georgakopoulos ND, et al. Among authors: gatliff j. Chembiochem. 2018 Sep 4;19(17):1810-1816. doi: 10.1002/cbic.201800170. Epub 2018 Jul 18. Chembiochem. 2018. PMID: 29927029 Free PMC article.

8

Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.

Kerr F, Sofola-Adesakin O, Ivanov DK, Gatliff J, Gomez Perez-Nievas B, Bertrand HC, Martinez P, Callard R, Snoeren I, Cochemé HM, Adcott J, Khericha M, Castillo-Quan JI, Wells G, Noble W, Thornton J, Partridge L. Kerr F, et al. Among authors: gatliff j. PLoS Genet. 2017 Mar 2;13(3):e1006593. doi: 10.1371/journal.pgen.1006593. eCollection 2017 Mar. PLoS Genet. 2017. PMID: 28253260 Free PMC article.

9

Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein-Protein Interaction Inhibitors with an Alternative Binding Mode.

Georgakopoulos N, Talapatra S, Dikovskaya D, Dayalan Naidu S, Higgins M, Gatliff J, Ayhan A, Nikoloudaki R, Schaap M, Valko K, Javid F, Dinkova-Kostova AT, Kozielski F, Wells G. Georgakopoulos N, et al. Among authors: gatliff j. J Med Chem. 2022 May 26;65(10):7380-7398. doi: 10.1021/acs.jmedchem.2c00457. Epub 2022 May 12. J Med Chem. 2022. PMID: 35549469 Free PMC article.

10

In My Best Interest.

Mayer PA, Esplin B, Burant CJ, Wilson BM, Krall ML, Daly BJ, Gatliff J. Mayer PA, et al. Among authors: gatliff j. Am J Hosp Palliat Care. 2017 Mar;34(2):160-165. doi: 10.1177/1049909115609576. Epub 2016 Jul 11. Am J Hosp Palliat Care. 2017. PMID: 26494828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page